Skip to content

Clinical trials

Neuroblastoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Country / region: Germany Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20052
20072
20101
20121
20133
20141
20152
20162
20171
20181
20193
20203
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting5
Terminated4
Unknown status4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
German Society for Pediatric Oncology and Hematology GPOH gGmbH3
University of Cologne3
Children's Hospital Medical Center, Cincinnati2
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2
St. Anna Kinderkrebsforschung2
AbbVie1
Bristol-Myers Squibb1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma34
Neoplasms9
Rhabdomyosarcoma6
Brain Neoplasms5
Glioma5
Medulloblastoma5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Recurrence5
Sarcoma, Ewing5
Leukemia, Myeloid, Acute4

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.